About | Free Trial

Last Update

2015-10-17T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Gary Woodnutt?

Dr. Gary Woodnutt

Vice President

Pfizer Inc

Direct Phone: (858) ***-****       

Pfizer Inc

235 E 42Nd St

New York, New York 10017

United States

Company Description

Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company applies science and its global resources to improve health and well-being at every stage of life. Pfizer�s diversified global health care portfolio includes human and ... more

Find other employees at this company (81,832)

Background Information

Employment History

Position, Pharmaceutical Industry
GlaxoSmithKline plc

Senior Vice President and Chief Scientific Officer
Lpath , Inc.

Affiliations

Speakers and Advisor
IBC USA Conferences , Inc.

Parent Member
Del Mar Union School District

Education

B.S. degree
Biochemistry and Physiology
University of Leeds

Bachelors degree
Biochemistry and Physiology
Leeds University

Ph.D

Ph.D degree
Biochemistry and Physiology
University of Reading

PhD

Reading University

Web References (35 Total References)


Executive Team | The Lpath Team | Lpath Incorporated

www.lpath.com [cached]

Gary Woodnutt, Ph.D. - Sr. Vice President & Chief Scientific Officer

Background: Dr. Woodnutt brings to Lpath extensive experience in drug discovery and pharmaceutical research. Prior to joining Lpath, Dr. Woodnutt served as the Vice President, Open Innovation at Pfizer/CovX, but his primary role at CovX, from 2006 to 2012, was as Vice President of Biology Research. From 2002 to 2006, Dr. Woodnutt was the Senior Vice President of Pharmaceutical Research and Development for Diversa Corporation. He began his career in the pharmaceutical industry with Glaxo SmithKline Pharmaceuticals, where he was employed for more than 20 years and rose to the position of Vice President and Head of Biology in the Antimicrobial and Host Defense Group. Dr. Woodnutt received his Ph.D. in biochemistry/physiology from the University of Reading, and he has authored numerous scientific articles.


Gary Woodnutt, Ph.D., Vice ...

www.PEGSummit.com [cached]

Gary Woodnutt, Ph.D., Vice President, Biology, CovX Pharmaceuticals, Inc., Pfizer

The utility of molecules that interact with two (or more) targets or that can interact in two places on the same target is generating much interest.


Gary Woodnutt , Ph.D. ...

phx.corporate-ir.net [cached]

Gary Woodnutt , Ph.D. has joined

...
Dr. Woodnutt brings to Lpath extensive experience in drug discovery and pharmaceutical research. Prior to joining Lpath , Dr. Woodnutt served as the Vice President, Open Innovation at Pfizer/CovX, but his primary role at CovX, from 2006 to 2012, was as Vice President of Biology Research . From 2002 to 2006, Dr. Woodnutt was the Senior Vice President of
...
. Dr. Woodnutt received his Ph.D. in biochemistry/physiology from the University of Reading , and he, too, has authored numerous scientific articles.
...
On the discovery and research side, Dr. Woodnutt will be invaluable in extending our category leadership in lipid-targeted antibodies as we continue to optimize our drug-discovery platform and add to our pipeline of novel and promising drug candidates."


Gary Woodnutt , Ph.D. ...

phx.corporate-ir.net [cached]

Gary Woodnutt , Ph.D. has joined

...
Dr. Woodnutt brings to Lpath extensive experience in drug discovery and pharmaceutical research. Prior to joining Lpath , Dr. Woodnutt served as the Vice President, Open Innovation at Pfizer/CovX, but his primary role at CovX, from 2006 to 2012, was as Vice President of Biology Research . From 2002 to 2006, Dr. Woodnutt was the Senior Vice President of
...
. Dr. Woodnutt received his Ph.D. in biochemistry/physiology from the University of Reading , and he, too, has authored numerous scientific articles.
...
On the discovery and research side, Dr. Woodnutt will be invaluable in extending our category leadership in lipid-targeted antibodies as we continue to optimize our drug-discovery platform and add to our pipeline of novel and promising drug candidates."


Lpath Incorporated - News Release

phx.corporate-ir.net [cached]

Gary Woodnutt , Ph.D. has joined

...
Dr. Woodnutt brings to Lpath extensive experience in drug discovery and pharmaceutical research. Prior to joining Lpath , Dr. Woodnutt served as the Vice President, Open Innovation at Pfizer/CovX, but his primary role at CovX, from 2006 to 2012, was as Vice President of Biology Research . From 2002 to 2006, Dr. Woodnutt was the Senior Vice President of
...
. Dr. Woodnutt received his Ph.D. in biochemistry/physiology from the University of Reading , and he, too, has authored numerous scientific articles.
...
On the discovery and research side, Dr. Woodnutt will be invaluable in extending our category leadership in lipid-targeted antibodies as we continue to optimize our drug-discovery platform and add to our pipeline of novel and promising drug candidates."

Similar Profiles

Other People with this Name

Other people with the name Woodnutt

Tom Woodnutt
Good Measures Limited

Samantha Woodnutt
Icon Moving Services LTD

Mark Woodnutt
The Stop Community Food Centre

John Woodnutt
Delmatic

Kelly Woodnutt
Hellenic Republic

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory